ID24524A - Kombinasi penghambat reduktase aldosa dan penghambat fosforilase glikogen - Google Patents

Kombinasi penghambat reduktase aldosa dan penghambat fosforilase glikogen

Info

Publication number
ID24524A
ID24524A IDW20000958A ID20000958A ID24524A ID 24524 A ID24524 A ID 24524A ID W20000958 A IDW20000958 A ID W20000958A ID 20000958 A ID20000958 A ID 20000958A ID 24524 A ID24524 A ID 24524A
Authority
ID
Indonesia
Prior art keywords
reductives
phosphereilase
glicogen
aldosa
obstacles
Prior art date
Application number
IDW20000958A
Other languages
English (en)
Indonesian (id)
Inventor
Banavara Lakshman Mylari
Dennis Jay Hoover
Bernard Hulin
Judith Lee Treadway
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ID24524A publication Critical patent/ID24524A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Superheterodyne Receivers (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Noise Elimination (AREA)
  • Enzymes And Modification Thereof (AREA)
IDW20000958A 1997-11-21 1998-11-02 Kombinasi penghambat reduktase aldosa dan penghambat fosforilase glikogen ID24524A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6636597P 1997-11-21 1997-11-21

Publications (1)

Publication Number Publication Date
ID24524A true ID24524A (id) 2000-07-20

Family

ID=22069038

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000958A ID24524A (id) 1997-11-21 1998-11-02 Kombinasi penghambat reduktase aldosa dan penghambat fosforilase glikogen

Country Status (38)

Country Link
EP (1) EP1032424B9 (fr)
JP (1) JP2002504478A (fr)
KR (2) KR20010032304A (fr)
CN (1) CN1279617A (fr)
AP (1) AP911A (fr)
AR (1) AR016423A1 (fr)
AT (1) ATE205403T1 (fr)
AU (1) AU733304B2 (fr)
BG (1) BG104435A (fr)
BR (1) BR9814698A (fr)
CA (1) CA2310069A1 (fr)
DE (1) DE69801680T2 (fr)
DK (1) DK1032424T3 (fr)
DZ (1) DZ2656A1 (fr)
EA (1) EA002365B1 (fr)
ES (1) ES2161548T3 (fr)
GR (1) GR3037071T3 (fr)
GT (1) GT199800166A (fr)
HR (1) HRP20000327A2 (fr)
HU (1) HUP0100272A3 (fr)
ID (1) ID24524A (fr)
IL (1) IL135713A0 (fr)
IS (1) IS5453A (fr)
MA (1) MA26568A1 (fr)
NO (1) NO20002164L (fr)
OA (1) OA11379A (fr)
PA (1) PA8462301A1 (fr)
PE (1) PE135399A1 (fr)
PL (1) PL340643A1 (fr)
PT (1) PT1032424E (fr)
SK (1) SK7222000A3 (fr)
TN (1) TNSN98211A1 (fr)
TR (1) TR200001451T2 (fr)
UA (1) UA57811C2 (fr)
UY (1) UY25258A1 (fr)
WO (1) WO1999026659A1 (fr)
YU (1) YU30700A (fr)
ZA (1) ZA9810636B (fr)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002536410A (ja) * 1999-02-12 2002-10-29 ノボ ノルディスク アクティーゼルスカブ 肥満の治療又は予防もしくは食欲の調節を目的とした薬学的組成物の製造におけるピロリジン誘導体の使用
EP1741445B1 (fr) 2000-01-21 2013-08-14 Novartis AG Combinaisons à base d'inhibiteurs de DPP-IV et d'antidiabetiques
CO5271699A1 (es) * 2000-01-24 2003-04-30 Pfizer Prod Inc Procedimiento para el tratamiento de cardiomiopatia utilizando inhibidores de la glucogeno fosforilasa
US6570013B2 (en) 2000-02-16 2003-05-27 Pfizer Inc Salts of zopolrestat
US6395767B2 (en) 2000-03-10 2002-05-28 Bristol-Myers Squibb Company Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
IL144507A0 (en) * 2000-07-31 2002-05-23 Pfizer Prod Inc Use of glycogen phosphorylase inhibitors to inhibit tumor growth
WO2002098429A1 (fr) * 2001-06-07 2002-12-12 Pfizer Products Inc. Formes salines du zopolrestat, a savoir ethanolamine, diethanolamine ou triethanolamine
GB0205175D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205162D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205165D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205166D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205170D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205176D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
US7057046B2 (en) 2002-05-20 2006-06-06 Bristol-Myers Squibb Company Lactam glycogen phosphorylase inhibitors and method of use
CA2392486A1 (fr) 2002-07-05 2002-12-08 Duchesnay Inc. Forme posologique pharmaceutique portant une inscription pour les femmes enceintes
US7098235B2 (en) 2002-11-14 2006-08-29 Bristol-Myers Squibb Co. Triglyceride and triglyceride-like prodrugs of glycogen phosphorylase inhibiting compounds
US7576121B2 (en) 2003-11-12 2009-08-18 Phenomix Corporation Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV
US7767828B2 (en) 2003-11-12 2010-08-03 Phenomix Corporation Methyl and ethyl substituted pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV
US7674913B2 (en) 2003-11-12 2010-03-09 Phenomix Corporation Heterocyclic boronic acid compounds
US7317109B2 (en) 2003-11-12 2008-01-08 Phenomix Corporation Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV
WO2006017292A1 (fr) 2004-07-12 2006-02-16 Phenomix Corporation Composes cyano contraints
WO2006055462A1 (fr) 2004-11-15 2006-05-26 Bristol-Myers Squibb Company Derives 2-amino-4- tetraline fonctionnalisee et inhibiteurs de la glycogene phosphorylase associes
US7365061B2 (en) 2004-11-15 2008-04-29 Bristol-Myers Squibb Company 2-Amino-3-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors
WO2006055435A1 (fr) 2004-11-15 2006-05-26 Bristol-Myers Squibb Company Derives de 2-aminonaphtalene et inhibiteurs de la glycogene phosphorylase associes
WO2006053274A2 (fr) 2004-11-15 2006-05-18 Bristol-Myers Squibb Company Derives de tetraline 2-amino-1-fonctionnalises et inhibiteurs correspondants de glycogene phosphorylase
EP2527337A1 (fr) 2005-04-14 2012-11-28 Bristol-Myers Squibb Company Inhibiteurs de la 11-bêta hydroxystéroïde déshydrogénase de type I
US7825139B2 (en) 2005-05-25 2010-11-02 Forest Laboratories Holdings Limited (BM) Compounds and methods for selective inhibition of dipeptidyl peptidase-IV
CA2622608C (fr) 2005-09-14 2014-08-19 Takeda Pharmaceutical Company Limited Administration d'inhibiteurs de dipeptidyl peptidase
EP2046753A2 (fr) 2006-07-06 2009-04-15 Brystol-Myers Squibb Company Inhibiteurs de type i de la 11-bêta hydroxystéroïde déshydrogénase pyridone/hydroxypyridine
US7727978B2 (en) 2006-08-24 2010-06-01 Bristol-Myers Squibb Company Cyclic 11-beta hydroxysteroid dehydrogenase type I inhibitors
JP2010524953A (ja) 2007-04-17 2010-07-22 ブリストル−マイヤーズ スクイブ カンパニー 縮合ヘテロ環１１−β−ヒドロキシステロイドデヒドロゲナーゼＩ型阻害剤
PE20090213A1 (es) 2007-05-04 2009-02-28 Bristol Myers Squibb Co Agonistas del receptor acoplado a la proteina g gpr119 [6,5]-biciclicos
WO2008137435A1 (fr) 2007-05-04 2008-11-13 Bristol-Myers Squibb Company Agonistes [6,6] and [6,7]-bicycliques du récepteur gpr 119 couplé à la protéine g
EA018709B1 (ru) 2007-07-17 2013-10-30 Бристол-Маерс Сквибб Компани Пиридоновые агонисты сопряженного с g-белком рецептора gpr119
TW201006821A (en) 2008-07-16 2010-02-16 Bristol Myers Squibb Co Pyridone and pyridazone analogues as GPR119 modulators
WO2011041293A1 (fr) 2009-09-30 2011-04-07 Takeda Pharmaceutical Company Limited Dérivés pyrazolo [1, 5—a] pyrimidines comme inhibiteurs de kinase 1 régulatrice de signal d'apoptose
SI2531501T1 (sl) 2010-02-03 2014-04-30 Takeda Pharmaceutical Company Limited Inhibitorji kinaze-1, ki regulirajo signal apoptoze
MX2012011460A (es) 2010-04-08 2012-11-23 Squibb Bristol Myers Co Analogos de pirimidinilpiperidiniloxipiridinona como moduladores de gpr119.
ES2559209T3 (es) 2010-04-14 2016-02-11 Bristol-Myers Squibb Company Nuevos activadores de la glucocinasa y métodos de uso de los mismos
EA201270778A1 (ru) 2010-05-06 2013-04-30 Бристол-Майерс Сквибб Компани Бициклические гетероарильные аналоги в качестве модуляторов рецептора gpr119
WO2011140161A1 (fr) 2010-05-06 2011-11-10 Bristol-Myers Squibb Company Analogues de benzofuranyle en tant que modulateurs de gpr119
RU2013135224A (ru) 2011-01-20 2015-03-10 Бионевиа Фармасьютикалс Инк. Композиции с модифицированным высвобождением эпалрестата или его производных и способы их использования
EP2850073B1 (fr) 2012-05-16 2017-07-19 Bristol-Myers Squibb Company Analogues de pyrimidinylpipéridinyloxypyridone en tant que modulateurs de gpr119
US9580422B2 (en) 2013-10-22 2017-02-28 Bristol-Myers Squibb Company Isotopically labeled triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
WO2018017910A1 (fr) 2016-07-22 2018-01-25 Bristol-Myers Squibb Company Activateurs de glucokinase et leurs procédés d'utilisation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4825448A (en) * 1986-08-07 1989-04-25 International Mobile Machines Corporation Subscriber unit for wireless digital telephone system
DE3889326D1 (de) * 1988-05-27 1994-06-01 Itt Ind Gmbh Deutsche Korrekturschaltung für ein digitales Quadratur-Signalpaar.
US5391551A (en) * 1993-05-10 1995-02-21 Pfizer Inc. Method of lowering blood lipid levels
EP0832066B1 (fr) * 1995-06-06 2001-09-12 Pfizer Inc. (indole-2-carbonyl-)-amides substitues en n et leurs derives, servant d'inhibiteurs de la glycogene phosphorylase
CA2342471C (fr) * 1995-06-06 2002-10-29 Judith L. Treadway Intermediaires amines de carbonyle-methyle heterocycliques

Also Published As

Publication number Publication date
OA11379A (en) 2004-01-28
UA57811C2 (uk) 2003-07-15
DE69801680D1 (de) 2001-10-18
IS5453A (is) 2000-04-14
NO20002164D0 (no) 2000-04-27
EA002365B1 (ru) 2002-04-25
KR20010032300A (ko) 2001-04-16
HRP20000327A2 (en) 2001-02-28
GR3037071T3 (en) 2002-01-31
PE135399A1 (es) 2000-01-15
UY25258A1 (es) 2000-12-29
ATE205403T1 (de) 2001-09-15
AP9801401A0 (en) 1998-12-31
EP1032424A1 (fr) 2000-09-06
KR20010032304A (ko) 2001-04-16
PA8462301A1 (es) 2000-05-24
WO1999026659A1 (fr) 1999-06-03
DE69801680T2 (de) 2002-02-07
KR100661214B1 (ko) 2006-12-26
ZA9810636B (en) 2000-05-22
GT199800166A (es) 2000-04-19
TR200001451T2 (tr) 2002-06-21
SK7222000A3 (en) 2001-09-11
PL340643A1 (en) 2001-02-12
TNSN98211A1 (fr) 2005-03-15
EP1032424B9 (fr) 2004-10-06
AR016423A1 (es) 2001-07-04
MA26568A1 (fr) 2004-12-20
CN1279617A (zh) 2001-01-10
EA200000433A1 (ru) 2000-12-25
CA2310069A1 (fr) 1999-06-03
BG104435A (bg) 2001-01-31
HUP0100272A2 (hu) 2001-06-28
JP2002504478A (ja) 2002-02-12
HUP0100272A3 (en) 2002-11-28
EP1032424B1 (fr) 2001-09-12
IL135713A0 (en) 2001-05-20
DZ2656A1 (fr) 2003-03-22
BR9814698A (pt) 2000-10-03
DK1032424T3 (da) 2001-11-19
YU30700A (sh) 2002-12-10
AU733304B2 (en) 2001-05-10
ES2161548T3 (es) 2001-12-01
AU9555898A (en) 1999-06-15
NO20002164L (no) 2000-07-19
PT1032424E (pt) 2001-12-28
AP911A (en) 2000-12-07

Similar Documents

Publication Publication Date Title
ID24524A (id) Kombinasi penghambat reduktase aldosa dan penghambat fosforilase glikogen
ID22807A (id) Hasil derifat 1-aril dan piridilpirazol untuk pestisida
ID19422A (id) Piridina dan bifenil tersubstitusi
ID27859A (id) Tampon dan metoda pembuatannya
DE69831755D1 (de) Optoakustische kontrastmittel und anwendungsverfahren
ID19385A (id) Adesif termosetting dan metoda pembuatannya
ID24839A (id) Senyawa-senyawa triazol dan penggunaannya
ID20463A (id) Turunan-turunan penil-dan aminofenil-alkilsulfonamida dan urea
ID23985A (id) Baterai dan metode pembuatannya
ID29591A (id) Senyawa-senyawa kuinolina dan kuinoksalina
ID23575A (id) Pirazolopirimidina-pirazolopirimidina dan pirazolotriazina-pirazolotriazina
ID23684A (id) Komposisi-polimer-organoclay dan pembuatannya
ID28114A (id) Sitokin mamalia; interleukin-b30 dan pereaksi-pereaksi terkait
ID26331A (id) Metode dan sistem untuk pita-pita kelipatan penarik
ID19833A (id) Aralkil dan aralkilidena heterosiklik laktam dan imida
ID16889A (id) Senyawa turunan alkilaminobenzotiazol dan benzoksazol
ID18456A (id) Produksi-bersama 6-aminokapronitril dan heksametilenadiamina
ID24695A (id) Metode dan konstruksi basemen anti lembab
ID18459A (id) Produksi-bersama 6-aminokapronitril dan heksametilenadiamina
ID28025A (id) Metode pembuatan aminonitril dan diamina
ID24463A (id) Metode meningkatkan ketersediaan hayati feksofenadin dan turunan-turunannya
ID23258A (id) Penarik pemberian-menyilang dan metodenya
ID16587A (id) Koproduksi 6-aminokapronitril dan heksametilendiamin
ID21847A (id) Komposisi insektisida dan metoda penggunaannya
ID21862A (id) Komposisi-komposisi insektisida dan mitisida